MIRA Pharmaceuticals Adjusts CFO Salary, Sets Annual Meeting
Company Announcements

MIRA Pharmaceuticals Adjusts CFO Salary, Sets Annual Meeting

The latest update is out from MIRA Pharmaceuticals, Inc. (MIRA).

MIRA Pharmaceuticals has revised its employment agreement with CFO Michelle Yanez, reducing her salary from $225,000 to $137,500 while allowing her to also serve other companies affiliated with Bay Shore Trust. Additionally, the company is gearing up for its first Annual Meeting of Shareholders on September 12, 2024, and has set a July 12 deadline for shareholder proposals and director nominations. This is a crucial time for investors to participate and engage with the company’s future direction.

See more insights into MIRA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyMira Pharmaceuticals announces preclinical data on Ketamir-2
TheFlyMIRA says Ketamir-2 outperforms FDA-approved neuropathic pain treatments
TheFlyMira Pharmaceuticals initiated with a Buy at Rodman & Renshaw
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App